Boston Scientific Corporation (BSX)
NYSE: BSX · IEX Real-Time Price · USD
72.09
+0.22 (0.31%)
May 1, 2024, 12:23 PM EDT - Market open

Boston Scientific Revenue

In the year 2023, Boston Scientific had annual revenue of $14.24B with 12.29% growth. Revenue in the quarter ending December 31, 2023 was $3.73B with 14.90% year-over-year growth.

Revenue (ttm)
$14.24B
Revenue Growth
+12.29%
P/S Ratio
7.42
Revenue / Employee
$296,667
Employees
48,000
Market Cap
105.99B USD

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202314.24B1.56B12.29%
Dec 31, 202212.68B794.00M6.68%
Dec 31, 202111.89B1.98B19.92%
Dec 31, 20209.91B-822.00M-7.66%
Dec 31, 201910.74B912.00M9.28%
Dec 31, 20189.82B775.00M8.57%
Dec 31, 20179.05B662.00M7.89%
Dec 31, 20168.39B909.00M12.16%
Dec 31, 20157.48B97.00M1.31%
Dec 31, 20147.38B237.00M3.32%
Dec 31, 20137.14B-106.00M-1.46%
Dec 31, 20127.25B-373.00M-4.89%
Dec 31, 20117.62B-184.00M-2.36%
Dec 31, 20107.81B-382.00M-4.67%
Dec 31, 20098.19B138.00M1.71%
Dec 31, 20088.05B-307.00M-3.67%
Dec 31, 20078.36B536.00M6.85%
Dec 31, 20067.82B1.54B24.48%
Dec 31, 20056.28B659.00M11.72%
Dec 31, 20045.62B2.15B61.80%
Dec 31, 20033.48B557.00M19.08%
Dec 31, 20022.92B246.00M9.20%
Dec 31, 20012.67B9.00M0.34%
Dec 31, 20002.66B-178.00M-6.26%
Dec 31, 19992.84B608.00M27.22%
Dec 31, 19982.23B403.00M22.01%
Dec 31, 19971.83B279.76M18.03%
Dec 31, 19961.55B360.42M30.27%
Dec 31, 19951.19B302.25M34.02%
Dec 31, 1994888.57M--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
CVS Health 357.78B
Cigna 195.27B
Elevance Health 171.75B
Sanofi 51.60B
Bristol-Myers Squibb Company 45.53B
Medtronic 32.32B
Stryker 20.50B
Regeneron Pharmaceuticals 13.12B
Revenue Rankings